Louis-Armstrong

Tag: NASH

medicine

Ionis announces third investigational antisense medicine to treat nonalcoholic steatohepatitis (NASH) enters development

November 23, 2020
[email protected]_84

CARLSBAD, Calif., Nov. 23, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that the biopharmaceutical company…